Broad Institute Receives $650 Million Gift for Psychiatric Research
the Psychiatry Advisor take:
The largest private donation for psychiatric research — $650 million — has been given to the Cambridge, Massachusetts-based Broad Institute by philanthropist and businessman Ted Stanley.
Stanley, who made his fortune heading a company that markets and sells collectibles, was moved to support mental health research after his son, Jonathan, was diagnosed with bipolar disorder in college. He was treated with lithium and is now a successful lawyer.
“Essentially, it gave him the ability to have a normal life with a normal functioning brain,” Stanley told The Boston Globe. “If I had had the same downfall at the same age that he had, I would have had my life ruined . . . because in between when I was that age and he was that age, someone had discovered that lithium makes people well when they have that illness.”
The Stanley Medical Research Institute had previously given the Broad a $175 million gift. The $650 million gift will not be given at once, but in annual payments with more after Stanley’s death.
Broad researchers contributed to the recent publication in Nature of the largest genomic study of schizophrenia. That study could lead to new treatments that target the molecular causes of the disease.
Philanthropist Gives $650 Million Gift for Psychiatric Research
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Should Physicians Treat Family and Friends? Three Experts Weigh In
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Dialectical Behavior Therapy Effective in Reducing Suicide Attempts, Self-Harm in Adolescents
- Influence of Psychostimulants on BMI and Height in Youth With ADHD
- Medication Adherence Predictors in Patients With Severe Psychiatric Disorders
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Substance Abuse and Primary Psychosis: A Closer Look
- Functional Restoration for Chronic Pain and Depression in the Elderly: Pharmacotherapy and Beyond
- Efficacy of Long-Acting Injectable Antipsychotics vs Oral Antipsychotics
- Older Age Associated With Worse Major Depressive Disorder Outcomes
- Preoperative Psychiatric Diagnoses Not Associated With Bariatric Surgery Outcomes
- Medical Clearance of Psych Patients in the ED: Consensus Recommendations